| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |